Margetuximab
Product Specifications
CAS Number
1350624-75-7
Target
HER, EGFR
Related Pathways
JAK/STAT signaling, Tyrosine Kinase/Adaptors, Angiogenesis
Purity
0.993
Bioactivity
Margetuximab (MGAH-22) is a second generation anti-human epidermal growth factor receptor 2 protein (HER2) monoclonal antibody with anti-tumor activity for the study of metastatic HER2-positive breast cancer and for the synthesis of nanomedicines.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV783454 1.0 µg DNA
RPS15AP38 Lentiviral Vector (Human) (EF1a) (pLenti-GIII-EF1a)
Sign In for Pricing
View Details 
MBS7259922-03 5x 96 Well
Goat Small Heterodimer Partner 2 ELISA Kit
Sign In for Pricing
View Details MBS7259922-04 10x 96 Well
Goat Small Heterodimer Partner 2 ELISA Kit
Sign In for Pricing
View Details